Skip to main content

Month: March 2025

Ascend Learning Announces Acquisition of Clover Learning to Expand Allied Health Education Offerings

Company continues its investment in advancing healthcare education among students and professionals to address national radiology workforce shortage LEAWOOD, Kan., March 27, 2025 (GLOBE NEWSWIRE) — Ascend Learning, a leading healthcare and learning software company, today announced the acquisition of Clover Learning, a pioneer in online diagnostic imaging education. Clover Learning enhances Ascend’s portfolio of allied health brands, furthering its mission to provide comprehensive training and certification solutions to healthcare professionals. As the US population ages, demand for medical imaging services is increasing and contributing to staffing challenges and shortages in the radiology workforce. Learning and upskilling to aid in retention and attracting new talent are critical needs in this workforce. “We are thrilled to...

Continue reading

Notice on convening the Extraordinary General Meeting of Shareholders of AB Akola Group

NOTICE TO THE SHAREHOLDERS OF AB AKOLA GROUPVilnius, 27 March 2025 Hereby we announce the Extraordinary General Meeting of Shareholders (hereinafter – the Meeting) of AB Akola Group, registered address Subačiaus St. 5, Vilnius, Lithuania, code 148030011, (hereinafter – the Company) is convened. The date, time, and venue of the Meeting – 29 April 2025 at 10.00 a.m., AB Akola Group office, Subačiaus St. 5, Vilnius, Lithuania. The accounting day of the Meeting is 22 April 2025. Only the persons who are the shareholders of the Company at the end of the Accounting day of the Meeting shall have the right to attend and vote at the Meeting. The Rights Accounting Day is 14 May 2025. Only the persons who are the shareholders of the Company at the end of the Rights Accounting day shall have proprietary rights. On the day the Meeting is convened the...

Continue reading

Urteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025

27 MARCH 2025                PRESS RELEASE Urteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025 Gdańsk, Poland – 27 March 2025 – Urteste S.A. (Warsaw Stock Exchange: URT), a company specializing in innovative technology for cancer detection through unique urine sample analysis, plans to initiate clinical trials in the European Union in Q3 2025 for the Panuri project—a diagnostic test for pancreatic cancer. In the coming weeks, Urteste will announce a tender to select a Contract Research Organization (CRO) to conduct the clinical trials. Additionally, the company is scheduled to hold its fourth Q-submission meeting with the FDA in mid-2025 to finalize details ahead of clinical trials in the United States. The European certification study will be conducted in Poland and selected EU countries, involving...

Continue reading

BIC: Release and Availability of the 2024 Universal Registration Document

Release and Availability of the 2024 Universal Registration Document Clichy, France – March 27, 2025 – The 2024 Universal Registration Document (French version) was filed with the A.M.F (Autorité des Marchés Financiers: French Financial Markets Authority) on March 27, 2025. The document is available on BIC’s website in French and English in the Investors’ section under Universal Registration Document as well as on the website of the A.M.F (www.amf-france.org). It is available to the public under current regulatory conditions. The 2024 Universal Registration Document contains XBRL tags (eXtensible Business Reporting Language) for its financial statements, as BIC adopted the European Single Electronic Format (ESEF). The document includes:the Annual Financial Report, the Management report of the Board of Directors for 2024, the Report on...

Continue reading

Oportun Comments on Director Nominations

SAN CARLOS, Calif., March 27, 2025 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT), a mission-driven financial services company, today confirmed receipt of a notice from Findell Capital Management LLC (“Findell”) nominating two directors to stand for election to the Oportun Board of Directors (the “Board”) at the Company’s 2025 Annual Meeting of Shareholders. The Board issued the following statement in response: Over the past three years, the Oportun Board of Directors has overseen decisive and deliberate actions to put the company on a strong path for long-term profitable growth. These actions, which we summarized in our press release on March 20, 2025, have led to improved credit performance, fortified our business economics and driven high-quality originations. Our business momentum and 2025 outlook speak for themselves and are a...

Continue reading

Zelluna ASA [ZLNA]: Key information regarding reverse share split and change of ISIN

Oslo, Norway, 27 March, 2025 Reference is made to the stock exchange notice published on 9 January 2025 regarding an extraordinary general meeting held in Zelluna ASA (the “Company“), where it was resolved to carry out a reverse share split in the ratio 10:1. Radforsk Investeringsstiftelse has further agreed with the Company to make available, without any compensation a, necessary number of its existing shares to the Company to ensure that all fractions of shares are rounded up to the nearest whole share, thus avoiding that shareholders will have its shareholdings rounded off downwards. Please note the following key information in relation to the reverse share split: – Date on which the corporate action was made public: 19 December 2024 (notice of extraordinary general meeting)– Date of approval: 9 January 2025...

Continue reading

VEON Returns to Capital Markets with Successful Syndication of USD 210 Million Term Loan

Dubai, March 27, 2025 – VEON Ltd. (Nasdaq: VEON), a global digital operator, today announces the successful syndication of a 24-month, USD 210 million senior unsecured term loan under a new facility agreement from a consortium of international lenders, including ICBC Standard Bank and leading GCC banks. “I am pleased to mark VEON’s return to the capital markets with the successful syndication of this new USD 210 million term loan from a group of leading international banks and investors. This new debt facility reflects the market’s strong confidence in VEON’s strategy, financial health, and future. The new financing not only strengthens our liquidity position but also reinforces our commitment to executing on our digital operator strategy to deliver growth and long-term value creation for all stakeholders,” said VEON Group CEO Kaan Terzioglu. “This...

Continue reading

WISeSat Prepares for June Launch of Its Second-Generation Satellite and Expands Global Footprint

WISeSat Prepares for June Launch of Its Second-Generation Satellite and Expands Global Footprint WISeSAT.space will be attending the 40th Space Symposium in Colorado Springs from April 6-10, 2025 (booth #808 located in the South Hall) Geneva, Switzerland – March 27, 2025 – WISeKey International Holding (“WISeKey” or the “Company”) (NASDAQ: WKEY; SIX: WIHN), a leading global cybersecurity, AI, and IoT company, alongside its subsidiary WISeSat.Space (“WISeSat”) today announces that the launch of its second-generation satellite is scheduled for June 2025. This follows the successful deployment of WISeSat’s first NDR-generation satellite in January 2025 aboard a SpaceX Falcon 9 rocket from Vandenberg Spaceport in California. The satellite launched in January is currently in orbit and its location can be tracked via https://wisesat.wisekey.com/?tags=WISeSat.This...

Continue reading

FERRARI: COMMERCIAL POLICY UPDATE

FERRARI: COMMERCIAL POLICY UPDATE Maranello, 27 March 2025 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) announces it will update its commercial policy, based on the preliminary information currently available regarding the introduction of import tariffs on EU cars into the USA. While reaffirming its commitment to maximum client attention and protection and with the goal to provide certainty to them:The commercial terms will remain unchanged for orders of all models imported before April 2, 2025 and for orders of the following three families – Ferrari 296, SF90 and Roma – regardless the import date. For the current remaining models, the new import conditions will be partially reflected on pricing, up to a maximum 10 per cent increase, in coordination with our dealer network.On such basis, Ferrari confirms...

Continue reading

Halcones Precious Metals Closes First Tranche of LIFE Offering

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, March 27, 2025 (GLOBE NEWSWIRE) — Halcones Precious Metals Corp. (TSX-V: HPM) (the “Company” or “Halcones”) announces that it has closed the first tranche of its previously-announced private placement of units (the “Offering”) of the Company (the “Units”) pursuant to which the Company issued 23,445,000 Units at a price of $0.07 per Unit for aggregate gross proceeds of $1,641,150 (the “First Tranche”). Each Unit is comprised of one common share in the capital of the Company (“Common Share”) and one-half of one Common Share purchase warrant (each whole warrant, a “Warrant”). Each Warrant entitles the holder to purchase one Common Share at an exercise...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.